AU2015221439B2 — Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
Assigned to Shionogi and Co Ltd · Expires 2016-07-14 · 10y expired
What this patent protects
H:Vbr\Interwoven\NRPortbl\DCC\RBR\8333683_I.docx-28/08/2015 Stable crystalline forms of a compound represented by the formula (IA): -HO HIN- NOA / -N (IA) 5 , an acid addition salt, and/or a solvate thereof are provided by the present invention. Said crystalline forms are extreme…
USPTO Abstract
H:Vbr\Interwoven\NRPortbl\DCC\RBR\8333683_I.docx-28/08/2015 Stable crystalline forms of a compound represented by the formula (IA): -HO HIN- NOA / -N (IA) 5 , an acid addition salt, and/or a solvate thereof are provided by the present invention. Said crystalline forms are extremely useful as materials for preparing medicines. Novel processes for preparing 6,7-unsaturated-7-carbamoyl morphinan derivatives are also provided by the present invention.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.